Table 2 NACRT regimen, effect of NACRT, and recurrence cases after surgery
From: Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
NACRT | ||
Radiation dose | 40 Gy | 11 |
50.4 Gy | 46 | |
Combination chemotherapy | 5′-DFUR | 31 |
Capecitabine | 19 | |
S1 | 7 | |
Histological antitumor effect of NACRT (grade) | 1a | 8 (14.0 %) |
1b | 18 (31.6 %) | |
2 | 24 (42.1 %) | |
3 | 7 (12.3 %) | |
Recurrence cases | Overall | 19 (33.3 %) |
Local | 3 | |
Lung | 7 | |
Liver | 4 | |
Distant lymph nodes | 2 | |
Peritoneum | 1 | |
Bone | 1 | |
Gluteus maximus | 1 | |